Literature DB >> 18186603

2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: a new antileishmanial chemotype.

Christina Reichwald1, Orly Shimony, Ute Dunkel, Nina Sacerdoti-Sierra, Charles L Jaffe, Conrad Kunick.   

Abstract

A screening program directed to find new agents against Leishmania donovani, the parasite causing visceral leishmaniasis, revealed that paullones attenuate the proliferation of axenic amastigotes. Because these structures were not active in a test system involving infected macrophages, a structure optimization campaign was carried out. Concomitant introduction of an unsaturated side chain into the 2-position and a tert-butyl substituent into the 9-position of the parent scaffold led to compounds inhibiting also parasites dwelling in macrophages. By inclusion of the so elaborated scaffold into a chalcone substructure, the toxicity against uninfected host cells was significantly reduced. For the synthesis of this new compound class, a novel modification of the Heck-type palladium-catalyzed C,C-cross coupling strategy was used, employing a ketone Mannich base as precursor for the alkene reactant. The so-prepared compounds exhibited improved antileishmanial activity both on axenic amastigotes (GI50 < 1 microM) as well as on parasites in infected macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186603     DOI: 10.1021/jm7012166

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Authors:  Andreas Link; Philipp Heidler; Marcel Kaiser; Reto Brun
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  (Z)-1-(2,4-Difluoro-phen-yl)-3-phenyl-2-(1H-1,2,4-triazol-1-yl)prop-2-en-1-one.

Authors:  Cong-Yan Yan; Guang-Zhou Wang; Cheng-He Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-31

4.  (2E)-1-[2-Hydr-oxy-4-(2-methyl-prop-oxy)phen-yl]-3-(4-methyl-phen-yl)prop-2-en-1-one.

Authors:  Jeshal G Maheta; Vijay M Barot; Mukesh M Jotani; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-27

5.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

6.  Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.

Authors:  Thomas Weidner; Leonardo Lucantoni; Abed Nasereddin; Lutz Preu; Peter G Jones; Ron Dzikowski; Vicky M Avery; Conrad Kunick
Journal:  Malar J       Date:  2017-05-15       Impact factor: 2.979

7.  High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.

Authors:  Nathalie Aulner; Anne Danckaert; Eline Rouault-Hardoin; Julie Desrivot; Olivier Helynck; Pierre-Henri Commere; Hélène Munier-Lehmann; Gerald F Späth; Spencer L Shorte; Geneviève Milon; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

8.  Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation.

Authors:  Samuel M Duncan; Elmarie Myburgh; Cintia Philipon; Elaine Brown; Markus Meissner; James Brewer; Jeremy C Mottram
Journal:  Mol Microbiol       Date:  2016-04-13       Impact factor: 3.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.